BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 5129528)

  • 1. Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 rubella vaccine.
    Cooper LZ; Florman AL; Ziring PR; Krugman S
    Am J Dis Child; 1971 Nov; 122(5):397-403. PubMed ID: 5129528
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 3. Attenuated rubella vaccine (HPV-77): evaluation in a large controlled trial.
    Lipman RP; Bethel MB; Wooten JH; Levine RH; Pagano JS
    Am J Public Health; 1971 Jul; 61(7):1392-402. PubMed ID: 4935166
    [No Abstract]   [Full Text] [Related]  

  • 4. An open community trial of live rubella vaccines. Study of vaccine virus transmissibility and antigenic efficacy of three HPV-77 derivatives.
    Veronelli JA
    JAMA; 1970 Sep; 213(11):1829-36. PubMed ID: 4917635
    [No Abstract]   [Full Text] [Related]  

  • 5. "Rubella virus vaccine, live".
    Clin Pediatr (Phila); 1970 Dec; 9(12):15A passim. PubMed ID: 5487471
    [No Abstract]   [Full Text] [Related]  

  • 6. Children immunized with HPV-77 rubella vaccine. Additional laboratory observations.
    Katz SL; Lang DJ; Wilfert CM; Feigin RD; Goldfein M
    Am J Dis Child; 1969 Aug; 118(2):213-7. PubMed ID: 4893822
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative field evaluation of three live, attenuated rubella virus vaccines.
    Kehrer AF; Isacson P
    Am J Public Health; 1971 Jan; 61(1):152-6. PubMed ID: 5539842
    [No Abstract]   [Full Text] [Related]  

  • 8. Attenuated rubella vaccination in families: observations on the lack of fluorescent antibody response and on the use of blood collected on filter paper discs in the hemagglutination-inhibition test.
    Monto AS; Cavallaro JJ; Brown GC
    J Lab Clin Med; 1969 Jul; 74(1):98-102. PubMed ID: 4892624
    [No Abstract]   [Full Text] [Related]  

  • 9. Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies.
    Wilkins J; Leedom JM; Portnoy B; Salvatore MA
    Am J Dis Child; 1969 Aug; 118(2):275-94. PubMed ID: 5794818
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 11. Rubella vaccine responses and other viral antibodies in Syracuse children.
    Lamb GA; Feldman HA
    Am J Dis Child; 1971 Aug; 122(2):117-21. PubMed ID: 5564154
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroepidemiology of rubella and reinfection.
    Enders-Ruckle G
    Am J Dis Child; 1969 Jul; 118(1):139-42. PubMed ID: 5790241
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine.
    Swartz TA; Klingberg W; Goldwasser RA; Klingberg MA; Goldblum N; Hilleman MR
    Am J Epidemiol; 1971 Sep; 94(3):246-51. PubMed ID: 5093654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rubella vaccination using Cendehill's live virus vaccine].
    Vivell O; Merschmann E; Lips G; Reiss G
    Arch Kinderheilkd; 1969 Sep; 179(3):259-66. PubMed ID: 5350790
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody response in school children to live rubella vaccine (Cendehill strain).
    Iwakata S; Elkerton LE; Rhodes AJ; Bull JA; Labzoffsky NA
    Can Med Assoc J; 1972 May; 106(9):980-2. PubMed ID: 4554732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fluorescent antibody induced by rubella virus in vaccinee and convalescent individuals.
    Serafini A; Cole GC; Brackett RG
    Appl Microbiol; 1972 Jan; 23(1):66-71. PubMed ID: 4621798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of antibody after subcutaneous vaccination with Wistar RA27/3 rubella vaccine.
    Hillary IB
    J Hyg (Lond); 1971 Sep; 69(3):369-72. PubMed ID: 5285940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with vaccination with attenuated rubella vaccine (strain HPV-77 adapted to duck cells, 5th passage)].
    Rocchi G; Salvadori A
    Nuovi Ann Ig Microbiol; 1970; 21(4):336-40. PubMed ID: 5518412
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination of infants with HPV-77 vaccine.
    Pavilanis V; Chagnon A; Davignon L; Joncas J
    Am J Dis Child; 1969 Aug; 118(2):247-51. PubMed ID: 4978509
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined live rubella-mumps virus vaccine. Findings in clinical-laboratory studies.
    Weibel RE; Stokes J; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
    JAMA; 1971 May; 216(6):983-6. PubMed ID: 5108387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.